0001615219-22-000087.txt : 20220531
0001615219-22-000087.hdr.sgml : 20220531
20220531171724
ACCESSION NUMBER: 0001615219-22-000087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220526
FILED AS OF DATE: 20220531
DATE AS OF CHANGE: 20220531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arthur David J.
CENTRAL INDEX KEY: 0001769331
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36812
FILM NUMBER: 22984686
MAIL ADDRESS:
STREET 1: 2450 HOLCOME BLVD.
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001615219
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465087339
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
BUSINESS PHONE: 346-772-0346
MAIL ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
FORMER COMPANY:
FORMER CONFORMED NAME: Flex Pharma, Inc.
DATE OF NAME CHANGE: 20140730
4
1
wf-form4_165403182105530.xml
FORM 4
X0306
4
2022-05-26
0
0001615219
Salarius Pharmaceuticals, Inc.
SLRX
0001769331
Arthur David J.
C/O SALARIUS PHARMACEUTICALS, INC.
2450 HOLCOME BLVD., SUITE X
HOUSTON
TX
77021
1
1
0
0
Chief Executive Officer
Common Stock
2022-05-26
4
P
0
3400
0.18
A
263074
D
Common Stock
2022-05-26
4
P
0
18600
0.182
A
281674
D
Common Stock
2022-05-26
4
P
0
708
0.18
A
282382
I
By son
Common Stock
2022-05-26
4
P
0
10392
0.1799
A
292774
I
By son
Common Stock
2022-05-26
4
P
0
10800
0.1843
A
303574
I
By daughter
The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
/s/Mark Rosenblum, as Attorney-in-Fact
2022-05-31